Cargando…

Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness

BACKGROUND: Group B Streptococcus (GBS) can cause invasive disease (iGBS) in young infants, typically presenting as sepsis or meningitis, and is also associated with stillbirth and preterm birth. GBS vaccines are under development, but their potential health impact and cost-effectiveness have not be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Procter, Simon R., Gonçalves, Bronner P., Paul, Proma, Chandna, Jaya, Seedat, Farah, Koukounari, Artemis, Hutubessy, Raymond, Trotter, Caroline, Lawn, Joy E., Jit, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013922/ https://www.ncbi.nlm.nih.gov/pubmed/36917564 http://dx.doi.org/10.1371/journal.pmed.1004068

Ejemplares similares

A review of the costs of delivering maternal immunisation during pregnancy
por: Procter, Simon R, et al.
Publicado: (2020)

Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods
por: Gonçalves, Bronner P., et al.
Publicado: (2021)

Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden
por: Gonçalves, Bronner P, et al.
Publicado: (2022)

Every Country, Every Family: Time to Act for Group B Streptococcal Disease Worldwide
por: Lawn, Joy E, et al.
Publicado: (2021)

Inferring longitudinal patterns of group B Streptococcus colonization during pregnancy
por: Gonçalves, Bronner P., et al.
Publicado: (2023)

Short- and Long-term Outcomes of Group B Streptococcus Invasive Disease in Mozambican Children: Results of a Matched Cohort and Retrospective Observational Study and Implications for Future Vaccine Introduction
por: Bramugy, Justina, et al.
Publicado: (2021)

20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention
por: Paul, Proma, et al.
Publicado: (2023)

Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina
por: Paul, Proma, et al.
Publicado: (2022)

South Indian Children’s Neurodevelopmental Outcomes After Group B Streptococcus Invasive Disease: A Matched-Cohort Study
por: John, Hima B, et al.
Publicado: (2021)

Quantifying long-term health and economic outcomes for survivors of group B Streptococcus invasive disease in infancy: protocol of a multi-country study in Argentina, India, Kenya, Mozambique and South Africa
por: Paul, Proma, et al.
Publicado: (2021)

Prematurity Modifies the Risk of Long-term Neurodevelopmental Impairments After Invasive Group B Streptococcus Infections During Infancy in Denmark and the Netherlands
por: Horváth-Puhó, Erzsébet, et al.
Publicado: (2021)

Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study
por: Horváth-Puhó, Erzsébet, et al.
Publicado: (2021)

Cost-effectiveness analysis of maternal vaccination against Group B streptococcus in Japan
por: Sorano, Sumire, et al.
Publicado: (2023)

Pathways from maternal depression to young adult offspring depression: an exploratory longitudinal mediation analysis
por: Koukounari, Artemis, et al.
Publicado: (2016)

Emotional and Behavioral Outcomes in Childhood for Survivors of Invasive Group B Streptococcus Disease in Infancy: Findings From 5 Low- and Middle-Income Countries
por: Chandna, Jaya, et al.
Publicado: (2021)

South African Children: A Matched Cohort Study of Neurodevelopmental Impairment in Survivors of Invasive Group B Streptococcus Disease Aged 5 to 8 Years
por: Harden, Lois M, et al.
Publicado: (2021)

Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation
por: Elliott, Alison M., et al.
Publicado: (2010)

Assessing the added value of group B Streptococcus maternal immunisation in preventing maternal infection and fetal harm: population surveillance study
por: Lamagni, T, et al.
Publicado: (2021)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Short-term and long-term risk of mortality and neurodevelopmental impairments after bacterial meningitis during infancy in children in Denmark and the Netherlands: a nationwide matched cohort study
por: Snoek, Linde, et al.
Publicado: (2022)

Human Nasal Challenge with Streptococcus pneumoniae Is Immunising in the Absence of Carriage
por: Wright, Adam K. A., et al.
Publicado: (2012)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

The need for a global COVID-19 maternal immunisation research plan
por: Bardají, Azucena, et al.
Publicado: (2021)

Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study
por: Auzenbergs, Megan, et al.
Publicado: (2023)

Cost optimisation analysis of the expanded programme for immunisation: balancing equity and coverage in Pakistan
por: Houdroge, Farah, et al.
Publicado: (2022)

Cost-Utility Analysis of Universal Maternal Pertussis Immunisation in Thailand: A Comparison of Two Model Structures
por: Botwright, Siobhan, et al.
Publicado: (2022)

Maternal pertussis immunisation: clinical gains and epidemiological legacy
por: Bento, Ana I, et al.
Publicado: (2017)

COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery
por: Toor, Jaspreet, et al.
Publicado: (2022)

A Global View of Immunisation
por: Poore, Peter
Publicado: (1987)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Quantifying the Acute Care Costs of Neonatal Bacterial Sepsis and Meningitis in Mozambique and South Africa
por: Aerts, Céline, et al.
Publicado: (2021)

A bibliometric analysis of systematic reviews on vaccines and immunisation
por: Fernandes, Silke, et al.
Publicado: (2018)

Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England
por: Cromer, Deborah, et al.
Publicado: (2017)

The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses
por: Zimmermann, Petra, et al.
Publicado: (2019)

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world
por: Postma, Maarten J, et al.
Publicado: (2011)

Programme costs in the economic evaluation of health interventions
por: Johns, Benjamin, et al.
Publicado: (2003)

Presentations at the UK National Immunisation Conference
por: Pollard, Andrew J, et al.
Publicado: (2022)

Variation in cost and performance of routine immunisation service delivery in India
por: Chatterjee, Susmita, et al.
Publicado: (2018)

Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program
por: Pecenka, Clint, et al.
Publicado: (2017)

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
por: Abbas, Kaja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t4jfue0tvr37sroeis58b5ed4a